A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique
- PMID: 33718219
- PMCID: PMC7953987
- DOI: 10.3389/fonc.2021.633556
A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique
Abstract
Objective: This study aimed to develop a least absolute shrinkage and selection operator (LASSO)-based multivariable normal tissue complication probability (NTCP) model to predict radiation-induced xerostomia in patients with nasopharyngeal carcinoma (NPC) treated with comprehensive salivary gland-sparing helical tomotherapy technique.
Methods and materials: LASSO with the extended bootstrapping technique was used to build multivariable NTCP models to predict factors of patient-reported xerostomia relieved by 50% and 80% compared with the level at the end of radiation therapy within 1 year and 2 years, R50-1year and R80-2years, in 203 patients with NPC. The model assessment was based on 10-fold cross-validation and the area under the receiver operating characteristic curve (AUC).
Results: The prediction model by LASSO with 10-fold cross-validation showed that radiation-induced xerostomia recovery could be predicted by prognostic factors of R50-1year (age, gender, T stage, UICC/AJCC stage, parotid Dmean, oral cavity Dmean, and treatment options) and R80-2years (age, gender, T stage, UICC/AJCC stage, oral cavity Dmean, N stage, and treatment options). These prediction models also demonstrated a good performance by the AUC.
Conclusion: The prediction models of R50-1year and R80-2years by LASSO with 10-fold cross-validation were recommended to validate the NTCP model before comprehensive salivary gland-sparing radiation therapy in patients with NPC.
Keywords: LASSO; helical tomotherapy technique; nasopharyngeal carcinoma; prediction model; xerostomia.
Copyright © 2021 Teng, Fan, Luo, Xu, Gong, Ge, Zhang, Wang and Ma.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.Sci Rep. 2015 Aug 20;5:13165. doi: 10.1038/srep13165. Sci Rep. 2015. PMID: 26289304 Free PMC article.
-
Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer.PLoS One. 2014 Feb 28;9(2):e89700. doi: 10.1371/journal.pone.0089700. eCollection 2014. PLoS One. 2014. PMID: 24586971 Free PMC article.
-
LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.Sci Rep. 2014 Aug 28;4:6217. doi: 10.1038/srep06217. Sci Rep. 2014. PMID: 25163814 Free PMC article.
-
Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.Radiother Oncol. 2023 Jul;184:109683. doi: 10.1016/j.radonc.2023.109683. Epub 2023 Apr 28. Radiother Oncol. 2023. PMID: 37120102
-
Statistical validation of normal tissue complication probability models.Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):e123-9. doi: 10.1016/j.ijrobp.2012.02.022. Epub 2012 Apr 27. Int J Radiat Oncol Biol Phys. 2012. PMID: 22541961
Cited by
-
Radiotherapy for head and neck tumours using an oral fixation and parameter acquisition device and TOMO technology: a randomised controlled study.BMJ Open. 2021 Nov 12;11(11):e052542. doi: 10.1136/bmjopen-2021-052542. BMJ Open. 2021. PMID: 34772753 Free PMC article. Clinical Trial.
-
A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.Aging (Albany NY). 2021 Jul 19;13(14):18645-18657. doi: 10.18632/aging.203308. Epub 2021 Jul 19. Aging (Albany NY). 2021. PMID: 34282056 Free PMC article.
-
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature selection.Clin Transl Radiat Oncol. 2024 Feb 28;46:100747. doi: 10.1016/j.ctro.2024.100747. eCollection 2024 May. Clin Transl Radiat Oncol. 2024. PMID: 38450218 Free PMC article.
-
Fine Motor Skill Decline After Brain Radiation Therapy-A Multivariate Normal Tissue Complication Probability Study of a Prospective Trial.Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):581-593. doi: 10.1016/j.ijrobp.2023.04.033. Epub 2023 May 6. Int J Radiat Oncol Biol Phys. 2023. PMID: 37150258 Free PMC article.
-
Cohort-based nomogram for forensic prediction of SCD: a single-center pilot study.Forensic Sci Med Pathol. 2025 Jun;21(2):653-664. doi: 10.1007/s12024-024-00920-6. Epub 2025 Jan 11. Forensic Sci Med Pathol. 2025. PMID: 39797964
References
LinkOut - more resources
Full Text Sources
Other Literature Sources